July 16, 2026 · O&G open · DOI: 10.1097/og9.0000000000000184

Postpartum Long-Acting Reversible Contraception Use Among People With Sickle Cell Disease in the United States

Listen to this summary

The authors aimed to assess the trends in the uptake of immediate postpartum long-acting reversible contraception (LARC) among individuals with and without sickle cell disease (SCD) using data from 2012 to 2019. They found that people with SCD had a significantly higher rate of immediate postpartum LARC uptake compared to those without SCD, even after adjusting for various clinical and demographic factors. These findings highlight the need for further investigation into the factors influencing contraception decisions among patients with complex medical conditions.

Preetha Nandi, Amy Luo, Anne Burke, Lydia H Pecker

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play